Public Company News

Veoneer Provides Market Update

* Announces Completion of Sale of Arriver            * Signs Strategic Collaboration Agreement with Qualcomm Technologies             * SSW Partners to Launch Process to Find Long-term Strategic Buyers STOCKHOLM andNEW YORK, April 5, 2022 /PRNewswire/ -- Veoneer, Inc., the automotive technol...

2022-04-05 00:49 3142

TSYS names Zwipe and adds insight to the previously announced partnership in North America

OSLO, Norway, April 5, 2022 /PRNewswire/ -- With reference to Zwipe's announcement on15 December 2021, biometric fintech pioneer Zwipe can confirm that TSYS, a leading global provider of payment services to card issuers (and part of Global Payments Inc, a member of the S&P 500), chose to work wit...

2022-04-05 00:47 3245

RISE Education to Hold Extraordinary General Meeting of Shareholders on April 29, 2022

BEIJING, April 4, 2022 /PRNewswire/ -- RISE Education Cayman Ltd ("RISE" or the "Company") (NASDAQ: REDU) today announced that it will hold an extraordinary general meeting of shareholders (the "EGM") at Room 101, Jia He Guo Xin Mansion, No. 15 Baiqiao Street Guangqumennei, Dongcheng District,Bei...

2022-04-04 23:13 4342

Sharing Economy International in joint venture with naked-eye 3D high-tech company Su Xin Rui Shi to lay out the underlying architecture of Metaverse technology

HONG KONG, April 4, 2022 /PRNewswire/ -- SHARING ECONOMY INTERNATIONAL INC (stock code: SEI", hereinafter referred to as "SEII") announced that its wholly-owned subsidiary 3D Discovery Co., Ltd ("3D Discovery") has entered into a strategic partnership withSuzhou Su Xin Rui Shi Technology Co., Ltd...

2022-04-04 23:10 4065

JX Luxventure Signs USD30,000,000 (3X 2020 Revenue) Sales Agreement

HAIKOU, China, April 4, 2022 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: LLL) (the "Company"), a service provider delivering comprehensive solutions to global elite families with business segments covering menswear, cross-border merchandise, airfare and tourism, announced today that, onMarch 3...

2022-04-04 23:01 3970

Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis

HONG KONG, April 4, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics," stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today dose administration for the first subject in a U.S. Phase I clinical tr...

2022-04-04 21:31 4211

ARTA TechFin Partners with Digital Technology of Insurance ("DTI") to Create Digital Insurance Platform in Greater Bay Area

  Technology Solutions, Wealth Management Industry Resource, Insurance Technology Innovation Centre in GBA by 2022Q3 ARTA: Break Barriers for Greatness HONG KONG, April 4, 2022 /PRNewswire/ -- Hong Kong's ARTA TechFin (00279.HK) ("ARTA") andChina's Digital Technology of Insurance ("DTI") today ...

2022-04-04 18:02 6662

TuanChe Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results

BEIJING, April 4, 2022 /PRNewswire/ -- TuanChe Limited ("TuanChe," "Company," "we" or "our") (NASDAQ: TC), a leading integrated automotive marketplace inChina , today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2021. Key Fourth Quarter 2021 Fi...

2022-04-04 18:00 4243

Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province

HANGZHOU, China and SHAOXING, China, April 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that the first sale of its ritonavir tablets inZhejiang Province has been completed. On April 3, 2022, Ascletis' distributor, Zhejiang Int'l Medicine Co., Ltd. ("Zhejiang Int'l"),...

2022-04-04 17:10 3895

Mycronic publishes Annual and Sustainability Report 2021

STOCKHOLM, April 4, 2022 /PRNewswire/ -- Mycronic AB (publ) today publishes its Annual and Sustainability Report 2021, which can be downloaded as a PDF from the company's websitewww.mycronic.com. A printed version of the Annual and Sustainability Report will be available mid-April and distribute...

2022-04-04 17:08 2625

Clarivate Healthcare Business Insights Announces 2021 Revenue Cycle Awards Recipients

Winners include Liberty Hospital, four Ardent Health Services hospitals, University of Iowa Hospitals & Clinics and Novant Health LONDON, April 4, 2022 /PRNewswire/ -- Today, Clarivate Healthcare Business InsightsTM , a part of Clarivate Plc (NYSE: CLVT), a global leader in providing trusted inf...

2022-04-04 16:00 2968

Hyundai Motor Group honors Infineon for supply competence and strategic cooperation for electric cars

MUNICH, Germany, April 4, 2022 /PRNewswire/ -- Hyundai Motor Group (HMG) has honored Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) as "Partner of the Year 2021" with the "Special Award for Supply Competence". The top global automaker recognized Infineon's efforts to stabilize uncertain suppl...

2022-04-04 15:00 5116

WA-based Golden State Mining announces new Payne's Find Lithium Project

PERTH, Australia, April 4, 2022 /PRNewswire/ -- Gold, lithium, and base metals exploration company Golden State Mining Limited (ASX code: "GSM") is substantially growing its' footprint acrossWestern Australia following the successful granting of two out of five tenement applications at GSM's new ...

2022-04-04 14:10 3118

Weidai Comments on Unusual Market Activity

HANGZHOU, China, April 4, 2022 /PRNewswire/ -- Weidai Ltd. (the "Company" or "Weidai") (NYSE: WEI), a leading auto-backed financing solution provider inChina , is issuing this press release in light of the unusual trading activity related to the American depositary shares (the "ADSs") of the Compa...

2022-04-04 13:41 4116

Offering Investors a 16-hour Trading Window, Moomoo Achieves Record User Number

SINGAPORE, April 4, 2022 /PRNewswire/ -- Moomoo, the next-generation one-stop digital financial service platform, announced that it had accumulated over 18 million users from more than 200 countries and regions with its sister brand. Meanwhile, since its launch in 2018, moomoo has been supporting...

2022-04-04 09:30 5838

Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project

MELBOURNE, Australia, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) Project, which has been awarded$23 million in Federal Government grant funding under t...

2022-04-04 09:13 4407

LG RECEIVES AHRI PERFORMANCE AWARD FOR FIFTH CONSECUTIVE YEAR

Company Secures Sought-after Industry Recognition for Its Advanced HVAC Solutions in Six Different Product Categories SEOUL, South Korea, April 4, 2022 /PRNewswire/ -- LG Electronics (LG) has been honored by the Air-Conditioning, Heating & Refrigeration Institute (AHRI) with a Performance Award ...

2022-04-04 09:00 3098

EQTEC Announces Expansion Strategy Update in Asia

Developing technology and commercial partnerships to meet waste management targets, reduce emissions, and growing demand for energy, hydrogen and biofuels in the ASEAN region andSouth Korea HONG KONG, April 4, 2022 /PRNewswire/ -- EQTEC plc (AIM: EQT, "the Company"), a world-leading technology c...

2022-04-04 09:00 4077

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

TIANJIN, April 4, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: 688185, HKEX: 06185) today announced that the National Medical Products Administration ofChina ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA vaccine inChina. Pr...

2022-04-04 08:30 5984

Innovent Releases Results of a Phase 3 Clinical Study of IBI306 (PCSK-9 inhibitor) in Chinese Patients with Heterozygous Familial Hypercholesterolemia at the American College of Cardiology Annual Congress 2022

SAN FRANCISCO and SUZHOU, China, April 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...

2022-04-04 08:00 4662